Caption Management’s Gossamer Bio GOSS Stock Holding History

Caption Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-891	Closed	-$23.4K	–	1819
2026 Q1	$23.4K	Sell	891 -51	-5%	-$6.41K	﹤0.01%	1451
2025 Q4	$234K	Buy	+942	New	+$215K	﹤0.01%	1355
2025 Q3	–	Sell	-319	Closed	-$56.3K	–	1816
2025 Q2	$31.3K	Buy	+319	New	+$27.8K	﹤0.01%	1353
2022 Q2	–	Sell	-299	Closed	-$185K	–	1590
2022 Q1	$207K	Buy	+299	New	+$231K	﹤0.01%	1268
2020 Q2	–	Sell	-500	Closed	-$406K	–	1035
2020 Q1	$406K	Buy	+500	New	+$522K	0.02%	586
2019 Q4	–	Sell	-3,149	Closed	-$5.07M	–	908
2019 Q3	$4.23M	Buy	+3,149	New	+$5.01M	0.22%	122

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Caption Management's GOSS Position: Q2 2026 in Review

Caption Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 891 shares — an estimated $23.4K sold.

Caption Management first reported a position in GOSS in Q3 2019 and held it in 6 quarters. The position peaked at $4.23M in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Caption Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
Caption Management sold 891 Gossamer Bio shares in Q2 2026, an estimated $23.4K.
Caption Management first reported a position in Gossamer Bio in Q3 2019 and held it in 6 quarters.
Caption Management's Gossamer Bio position peaked at $4.23M in Q3 2019.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.